A MUM whose low iron levels were flagged when she tried to donate blood was shocked to discover it was a sign of bowel cancer ...

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...

Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.

Older adults who undergo high-risk emergency general surgery spend significantly fewer days living independently at home ...

Nineteen patients have already undergone Robotic Assisted Surgery in the last six weeks using the new state-of-the-art system ...

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

Johnson & Johnson has won U.S. Food and Drug Administration marketing authorization for its Ottava robotic surgical system. J&J on Wednesday said the FDA green light covers Ottava, the world's first ...

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...

Johnson & Johnson (JNJ) wins FDA's De Novo authorization for the company’s soft tissue robotic system, Ottava. Read more here.

Older adults who undergo high-risk emergency general surgery spend significantly fewer days living independently at home ...

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.